XCUR

Exicure, Inc.

0.55 USD
-0.04 (-7.19%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Exicure, Inc. stock is down -1.77% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 February’s closed higher than January.

About Exicure, Inc.

Exicure, Inc. develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders.